LIQTECH INTERNATIONAL INC (LIQT): Entry into a Material Definitive Agreement
LIQTECH INTERNATIONAL INC (LIQT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 ex_974332.htm EXHIBIT 1.1 ex_974332.htm Exhibit 1.1 LIQTECH INTERNATIONAL, INC. 20,000,000 SHARES OF COMMON STOCK __________________________ Underwriting Agreement June 4, 2026 Konik Capital Partners LLC, a division of T.R. Winston & Company, LLC 7 World Trade Center, 46
How this was made
The 30-second read
Why it matters
This is a primary financing disclosure that can change near-term supply/demand for the stock once pricing is set, and it may affect valuation expectations depending on proceeds and intended use.
Market read
A new registered equity offering framework is disclosed; traders should monitor the subsequent pricing/prospectus details for dilution magnitude and proceeds/use-of-funds implications.
What to watch
Traders will need the final prospectus/pricing terms (offering price, net proceeds, use of proceeds, and whether insiders participate) to judge whether the dilution is offset by growth/capital-structure benefits.
Background
The article is an SEC Form 8-K (Item 1.01) describing LiqTech’s entry into a material definitive underwriting agreement with Konik Capital Partners for a registered common-stock offering, including an option to purchase additional shares.
Ticker impact
LiqTech entered a material definitive underwriting agreement for a registered common-stock offering (firm shares plus an over-allotment option).
Near-term downside risk from dilution/overhang is plausible, with magnitude depending on offering size/price (not provided in the excerpt).
An 8-K Item 1.01 for an underwriting agreement is a primary catalyst; however, the excerpt does not include the offering price, gross proceeds, or use of proceeds, limiting precision on dilution impact.
Market effects
Microcap/small-cap equity issuance can modestly affect sentiment toward similar capital-needy issuers, but no sector-wide mechanism is described here.
No specific regional linkage beyond US capital markets/SEC filing mechanics.
Limited; this is company-specific financing disclosure with no cross-border deal terms in the excerpt.
Counterpoint
If the offering is priced attractively and funds accretively (use of proceeds not shown), the market may re-rate the balance-sheet outlook rather than treat it purely as dilution.
Key entities
- issuerLiqTech International, Inc.
Company entering the underwriting agreement for a registered common-stock offering (firm shares plus an over-allotment option).
- underwriterKonik Capital Partners LLC
Underwriter for the firm shares and potential option shares under the agreement.
